Clinical Trials Directory

Trials / Completed

CompletedNCT01732705

High Intensity Interval Training (HIT) in Patients With Type 2 Diabetes

Effect of High Intensity Interval Training (HIT) on Insulin Sensitivity in Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of High Intensity Interval Training (HIT) on insulin sensitivity in skeletal muscle in patients with type 2 diabetes.

Detailed description

Physical exercise increases insulin sensitivity in skeletal muscle in healthy as well as in individuals with type 2 diabetes, but implies a considerable time commitment. High intensity interval training (HIT) is time-efficient exercise consisting of repeated bouts of short duration high intensive workloads. The aim of this study is to determine the effect of HIT in patients with type 2 diabetes, and to clarify the mechanisms of a possible positive effect of HIT. Exercise is performed as 2 weeks one-legged training on an ergometer bicycle. Thus one leg serves as a control leg. Insulin sensitivity in trained and non-trained muscle will be measured after completion of the overall training program by euglycemic hyperinsulinemic clamp method and a-v catheterization of both legs. Muscle biopsies will be obtained during training period for measuring of muscle glycogen content, and muscle biopsies for further analysis obtained during the experimental day.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh intensity interval trainingHIT will be conducted as 2 weeks of one legged high intense interval training (8 sessions every 2nd day). Each training session will consist of 10 x 1 min intervals on ergometer bicycle interspersed with 1 min recovery.

Timeline

Start date
2012-09-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-11-26
Last updated
2021-02-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01732705. Inclusion in this directory is not an endorsement.